Aqr Capital Management LLC Tricida, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$8.51 - $13.6 $170,965 - $273,224
20,090 New
20,090 $211,000
Q2 2020

Aug 17, 2020
SELL
$21.21 - $31.55 $270,978 - $403,082
-12,776 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$18.43 - $38.04 $30,188 - $62,309
1,638 Added 14.71%
12,776 $281,000
Q4 2019

Feb 14, 2020
BUY
$29.6 - $43.71 $329,684 - $486,841
11,138 New
11,138 $420,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email